ATE534741T1 - Protozoanstamm der spezies leishmania infantum mit reduzierter virulenz und dessen verwendung - Google Patents

Protozoanstamm der spezies leishmania infantum mit reduzierter virulenz und dessen verwendung

Info

Publication number
ATE534741T1
ATE534741T1 AT04805294T AT04805294T ATE534741T1 AT E534741 T1 ATE534741 T1 AT E534741T1 AT 04805294 T AT04805294 T AT 04805294T AT 04805294 T AT04805294 T AT 04805294T AT E534741 T1 ATE534741 T1 AT E534741T1
Authority
AT
Austria
Prior art keywords
strain
leishmania infantum
reduced virulence
protozoan
protozoan strain
Prior art date
Application number
AT04805294T
Other languages
English (en)
Inventor
Da Silva Anabela Cordeira
Ali Ouaissi
Denis Sereno
Jean-Baptiste Vergnes
Original Assignee
Inst Rech Developpement Ird
Univ Do Porto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Rech Developpement Ird, Univ Do Porto filed Critical Inst Rech Developpement Ird
Application granted granted Critical
Publication of ATE534741T1 publication Critical patent/ATE534741T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/68—Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT04805294T 2003-10-29 2004-10-25 Protozoanstamm der spezies leishmania infantum mit reduzierter virulenz und dessen verwendung ATE534741T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0312689A FR2861740B1 (fr) 2003-10-29 2003-10-29 Souches de protozoaire de virulence attenuee et leur utilisation
PCT/FR2004/002735 WO2005044844A2 (fr) 2003-10-29 2004-10-25 Souches de protozoaire de virulence attenuee et leur utilisation

Publications (1)

Publication Number Publication Date
ATE534741T1 true ATE534741T1 (de) 2011-12-15

Family

ID=34429739

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04805294T ATE534741T1 (de) 2003-10-29 2004-10-25 Protozoanstamm der spezies leishmania infantum mit reduzierter virulenz und dessen verwendung

Country Status (8)

Country Link
US (1) US7732188B2 (de)
EP (1) EP1678305B1 (de)
AT (1) ATE534741T1 (de)
AU (1) AU2004286879B2 (de)
CA (1) CA2543866A1 (de)
ES (1) ES2393610T3 (de)
FR (1) FR2861740B1 (de)
WO (1) WO2005044844A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713297B2 (en) 1998-04-11 2010-05-11 Boston Scientific Scimed, Inc. Drug-releasing stent with ceramic-containing layer
US20070224235A1 (en) 2006-03-24 2007-09-27 Barron Tenney Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8187620B2 (en) 2006-03-27 2012-05-29 Boston Scientific Scimed, Inc. Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
US8815275B2 (en) 2006-06-28 2014-08-26 Boston Scientific Scimed, Inc. Coatings for medical devices comprising a therapeutic agent and a metallic material
EP2032091A2 (de) 2006-06-29 2009-03-11 Boston Scientific Limited Medizinprodukte mit selektiver beschichtung
JP2010503469A (ja) 2006-09-14 2010-02-04 ボストン サイエンティフィック リミテッド 薬物溶出性皮膜を有する医療デバイス
US7981150B2 (en) 2006-11-09 2011-07-19 Boston Scientific Scimed, Inc. Endoprosthesis with coatings
US8431149B2 (en) 2007-03-01 2013-04-30 Boston Scientific Scimed, Inc. Coated medical devices for abluminal drug delivery
US8070797B2 (en) 2007-03-01 2011-12-06 Boston Scientific Scimed, Inc. Medical device with a porous surface for delivery of a therapeutic agent
US8067054B2 (en) 2007-04-05 2011-11-29 Boston Scientific Scimed, Inc. Stents with ceramic drug reservoir layer and methods of making and using the same
US7976915B2 (en) 2007-05-23 2011-07-12 Boston Scientific Scimed, Inc. Endoprosthesis with select ceramic morphology
US7942926B2 (en) 2007-07-11 2011-05-17 Boston Scientific Scimed, Inc. Endoprosthesis coating
US8002823B2 (en) 2007-07-11 2011-08-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
US9284409B2 (en) 2007-07-19 2016-03-15 Boston Scientific Scimed, Inc. Endoprosthesis having a non-fouling surface
US8815273B2 (en) 2007-07-27 2014-08-26 Boston Scientific Scimed, Inc. Drug eluting medical devices having porous layers
US7931683B2 (en) 2007-07-27 2011-04-26 Boston Scientific Scimed, Inc. Articles having ceramic coated surfaces
WO2009018340A2 (en) 2007-07-31 2009-02-05 Boston Scientific Scimed, Inc. Medical device coating by laser cladding
JP2010535541A (ja) 2007-08-03 2010-11-25 ボストン サイエンティフィック リミテッド 広い表面積を有する医療器具用のコーティング
US8029554B2 (en) 2007-11-02 2011-10-04 Boston Scientific Scimed, Inc. Stent with embedded material
US7938855B2 (en) 2007-11-02 2011-05-10 Boston Scientific Scimed, Inc. Deformable underlayer for stent
US8216632B2 (en) 2007-11-02 2012-07-10 Boston Scientific Scimed, Inc. Endoprosthesis coating
FR2924611B1 (fr) * 2007-12-07 2012-10-12 Isabelle Delbosc Nouvelle souche homeopathique comprenant un nosode de protozoaire du genre trypanosoma
JP5581311B2 (ja) 2008-04-22 2014-08-27 ボストン サイエンティフィック サイムド，インコーポレイテッド 無機材料のコーティングを有する医療デバイス及びその製造方法
WO2009132176A2 (en) 2008-04-24 2009-10-29 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers
WO2009155328A2 (en) 2008-06-18 2009-12-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
US8231980B2 (en) 2008-12-03 2012-07-31 Boston Scientific Scimed, Inc. Medical implants including iridium oxide
US8071156B2 (en) 2009-03-04 2011-12-06 Boston Scientific Scimed, Inc. Endoprostheses
US8287937B2 (en) 2009-04-24 2012-10-16 Boston Scientific Scimed, Inc. Endoprosthese
TWI843791B (zh) * 2019-01-09 2024-06-01 香港商港大科橋有限公司 對疫苗接種增強免疫反應及改良疫苗生產的組成物及方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09502091A (ja) 1993-09-03 1997-03-04 マックギル ユニヴァーシティー 特異的に発現するリーシュマニア遺伝子及び蛋白質
US5965143A (en) * 1996-03-12 1999-10-12 Fasel; Nicolas Joseph Immunity to trypanosomatids species
US6162638A (en) 1996-05-06 2000-12-19 Universite Laval Attenuated strains of leishmania and uses thereof
GB9706930D0 (en) 1997-04-04 1997-05-21 Univ Glasgow Leishmania vaccine
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
FR2861740B1 (fr) 2005-12-16
WO2005044844A2 (fr) 2005-05-19
FR2861740A1 (fr) 2005-05-06
CA2543866A1 (fr) 2005-05-19
EP1678305A2 (de) 2006-07-12
EP1678305B1 (de) 2011-11-23
US20070224224A1 (en) 2007-09-27
AU2004286879B2 (en) 2010-07-22
ES2393610T3 (es) 2012-12-26
WO2005044844A3 (fr) 2005-07-07
US7732188B2 (en) 2010-06-08
AU2004286879A1 (en) 2005-05-19

Similar Documents

Publication Publication Date Title
FR2861740B1 (fr) Souches de protozoaire de virulence attenuee et leur utilisation
CY1115361T1 (el) Στερεες μορφες περιλαμβανοντας (+)-2-[1-(3-αιθοξυ-4-μεθοξυφαινυλ)-2-μεθυλσουλφονυλαιθυλ]-4-ακετυλαμινοϊσοϊνδολιν-1,3-διονη, συνθεσεις εξ' αυτων, και χρησεις εξ' αυτων
EP1649006A4 (de) Exo-spezifische amylase-polypeptide, diese polypeptide codierende nukleinsäuren und verwendungen davon
NO20080074L (no) Modifiserte mikroorganismer med inaktivert lactat-dehydrogenasegen
ATE449840T1 (de) Alpha-amylasevariante mit veränderten eigenschaften
CY1110995T1 (el) Ασφαλη μεταλλακτικα ιικα εμβολια
CR10263A (es) Induccion y estabilizacion de actividad enzimatica en microorganismos
SG142154A1 (en) Methods for genomic analysis
BR0214787A (pt) Compósitos elastoméricos, combinações de elastÈmeros e métodos
ATE507721T2 (de) Milbenzusammensetzung
HUP0400393A2 (hu) Eljárás vírusszaporításra
DK1735439T3 (da) Spaltning af VEGF og VEGF receptor ved hjælp af vild-type og mutant MT-SP1
EP4450631A4 (de) Verwendung von oxidoreduktase und mutant davon in der biosynthese von nootkaton
EP1710300A4 (de) Hochsicheres pocken-vakzine-virus und vaccinia-virus-vektor
DK1390543T3 (da) Nye polynukleotider og polypeptider af IFNalfa-17-genet
EP4365286A4 (de) Esterasemutante und verwendung davon
EP4276178A4 (de) Esterasemutante und verwendung davon
DK1753512T3 (da) Tetrahydropyridothiophener
DE60317693D1 (de) Methode und verwendung von thermostabilen rna-ligasen
DE60228089D1 (de) Nukleinsäureamplifikation mit duplexzwischenprodukten
MX2011007989A (es) Marcadores para predecir y verificar la respuesta a terapia de inhibidor de aurora cinasa b.
MX2023008773A (es) Composicion de vacuna para romper la autotolerancia.
ATE435291T1 (de) Allele des glucokinasegens von coryneformen bakterien
ATE549026T1 (de) Verwendung von pinitol zur behandlung von leberkrankheiten in säugetieren
EP1642969A4 (de) Fluoreszenzprotein und pigmentprotein